Clinical Trial Update: Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of a radiolabeled monoclonal antibody for patients with previously treated large cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Radiolabeled monoclonal antibody

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lymphoma | Phase 1 | Status: COMPLETED